These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 27387266)
1. Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis. Choi MY; Fritzler MJ Curr Opin Rheumatol; 2016 Nov; 28(6):586-94. PubMed ID: 27387266 [TBL] [Abstract][Full Text] [Related]
2. Autoantibody profiles in systemic sclerosis; a comparison of diagnostic tests. Alkema W; Koenen H; Kersten BE; Kaffa C; Dinnissen JWB; Damoiseaux JGMC; Joosten I; Driessen-Diks S; van der Molen RG; Vonk MC; Smeets RL Autoimmunity; 2021 May; 54(3):148-155. PubMed ID: 33818234 [TBL] [Abstract][Full Text] [Related]
3. Very early diagnosis of systemic sclerosis. Bellando-Randone S; Guiducci S; Matucci-Cerinic M Pol Arch Med Wewn; 2012; 122 Suppl 1():18-23. PubMed ID: 23222375 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis. Yaqub A; Chung L Curr Rheumatol Rep; 2013 Jan; 15(1):302. PubMed ID: 23292818 [TBL] [Abstract][Full Text] [Related]
6. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499 [TBL] [Abstract][Full Text] [Related]
7. Autoantibody profile in a cohort of Algerian patients with systemic sclerosis. Tahiat A; Allam I; Abdessemed A; Mellal Y; Nebbab R; Ladjouze-Rezig A; Djidjik R Ann Biol Clin (Paris); 2020 Apr; 78(2):126-133. PubMed ID: 32175889 [TBL] [Abstract][Full Text] [Related]
8. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis. Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743 [TBL] [Abstract][Full Text] [Related]
9. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity. Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450 [TBL] [Abstract][Full Text] [Related]
11. Detecting gastrointestinal manifestations in patients with systemic sclerosis using anti-gAChR antibodies. Nakane S; Umeda M; Kawashiri SY; Mukaino A; Ichinose K; Higuchi O; Maeda Y; Nakamura H; Matsuo H; Kawakami A Arthritis Res Ther; 2020 Feb; 22(1):32. PubMed ID: 32085768 [TBL] [Abstract][Full Text] [Related]
12. Insights into origins and specificities of autoantibodies in systemic sclerosis. Tiniakou E; Crawford J; Darrah E Curr Opin Rheumatol; 2021 Nov; 33(6):486-494. PubMed ID: 34506340 [TBL] [Abstract][Full Text] [Related]
13. The concept of early systemic sclerosis following 2013 ACR\EULAR criteria for the classification of systemic sclerosis. Valentini G; Marcoccia A; Cuomo G; Iudici M; Vettori S Curr Rheumatol Rev; 2014; 10(1):38-44. PubMed ID: 24720644 [TBL] [Abstract][Full Text] [Related]
14. Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc). Valentini G Autoimmun Rev; 2015 Mar; 14(3):210-3. PubMed ID: 25461837 [TBL] [Abstract][Full Text] [Related]
15. Autoantibodies are present before the clinical diagnosis of systemic sclerosis. Burbelo PD; Gordon SM; Waldman M; Edison JD; Little DJ; Stitt RS; Bailey WT; Hughes JB; Olson SW PLoS One; 2019; 14(3):e0214202. PubMed ID: 30913258 [TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis in adults. Part I: Clinical features and pathogenesis. Jerjen R; Nikpour M; Krieg T; Denton CP; Saracino AM J Am Acad Dermatol; 2022 Nov; 87(5):937-954. PubMed ID: 35131402 [TBL] [Abstract][Full Text] [Related]
17. To what extent do autoantibodies help to identify high-risk patients in systemic sclerosis? Boonstra M; Mertens BJA; Bakker JA; Ninaber MK; Ajmone Marsan N; van der Helm-van Mil AHM; Scherer HU; Huizinga TWJ; de Vries-Bouwstra JK Clin Exp Rheumatol; 2018; 36 Suppl 113(4):109-117. PubMed ID: 30148428 [TBL] [Abstract][Full Text] [Related]
18. Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers. Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A Arthritis Res Ther; 2013; 15(3):R63. PubMed ID: 23718566 [TBL] [Abstract][Full Text] [Related]
19. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil]. Coelho Horimoto AM; da Costa IP Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063 [TBL] [Abstract][Full Text] [Related]
20. Scleroderma autoantibodies in guiding monitoring and treatment decisions. Shah S; Denton CP Curr Opin Rheumatol; 2022 Nov; 34(6):302-310. PubMed ID: 36082759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]